Contract Awarded

SURGICAL INNOVATIONS GROUP PLC
7 October 1999

     SURGICAL INNOVATIONS WIN £170,000 CONTRACT IN TURKEY
                 FOR AUTOLOGOUS BLOOD PRODUCTS
  Surgical Innovations also takes gold in top industry awards
                               
Surgical  Innovations Group plc, the Aim  listed  provider  of
healthcare products primarily for the operating theatre, today
announces  that  it  has  secured a  contract  to  supply  its
autologous  blood  products to Turkish  distributor  Mikromed,
which specialises in this field.  Orders for staged deliveries
over  the  next  12  months  have been  agreed  in  excess  of
£170,000.

Commenting on the new deal, Ian Lomas Managing Director  said:
'This  new deal clearly shows that previous production  delays
relating  to  the  autologous blood  products  are  now  being
overcome.'   He  continued: 'Turkey has  an  advanced  medical
market,  which is difficult to enter and this deal is a  great
endorsement for our products.'

Following  initial discussions with Surgical  Innovations  the
Turkish distributor carried out market research to assess  the
demand for autologous blood products in its country and  found
it to be considerable.  The majority of the order is to supply
the  Intra-operative  system  (Haemocell  ABT),  although  the
distributor  will carry the full range of blood  products.   A
further  market research study is now underway to  assess  the
opportunity for the company's keyhole surgery devices.

Surgical  Innovations has also won the Gold Award at  the  PRW
awards for excellence for its new F4 product.  The F4 is a new
handle design for keyhole surgery instruments.
                               
The  awards  are  held  only every three  years  and  Surgical
Innovations beat hundreds of nominations from a broad spectrum
of  industries.  Previous winners of the Gold Award,  such  as
Glaxo  Wellcome's multi-dose powder inhaler, have gone  on  to
become market leaders in their field.

The  F4 has been under development for 2.5 years and is set  to
become the next leading product for Surgical Innovations.   It
is  due  to  be launched in the Autumn, although an order  has
already  been secured for the handle sets from a US instrument
company.

Ian  Lomas  commented: 'Surgical Innovations prides itself  on
being  at  the leading edge of technology for keyhole surgery.
We  have always placed great emphasis on R&D and an award like
this shows the value of that investment.'

For further information contact:

Surgical Innovations Group plc          Citigate Dewe Rogerson
Ian Lomas                                     Keeley Middleton
Tel: [phone]                          Tel: [phone]